E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt SignalingCANCER RESEARCHIF16.62021-02-1537OA
E7386, an orally active CBP/beta-catenin modulator, induces T cells infiltration into tumor and enhances antitumor activity of anti-PD-1 mAb in Wnt1 tumor syngeneic mice modelCANCER RESEARCHIF16.62017-07-011PRE
E7386: First-in-class orally active CBP/beta-catenin modulator as an anticancer agentCANCER RESEARCHIF16.62017-07-012PRE
Plucked hair as a platform for monitoring pharmacodynamic and mechanistic consequences of clinical exposure to the Wnt/beta-catenin inhibitor PRI-724EUROPEAN JOURNAL OF CANCERIF7.12014-11-010PREAI
Three-Dimensional Structural Diversity-Oriented Peptidomimetics Based on the Cyclopropylic StrainORGANIC LETTERSIF52013-03-2523PREAI
Identification of new agonists of urotensin-II from a cyclic peptide libraryBIOORGANIC & MEDICINAL CHEMISTRYIF32009-09-014PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向